Skip to content

Efficacy of low dose thiopental in conscious sedation

Efficacy of low dose thiopental in conscious sedation

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20160110001
Enrollment
36
Registered
2016-01-10
Start date
2015-12-19
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

low blood pressure&#44

Interventions

inject thiopental Thiopental (50 mg/mL) 2 mL before inject 1% xylocaine with adrenaline 1:200000,inject 0.9% Normal saline 2 mL before inject 1% xylocaine with adrenaline 1:200000
Experimental Drug,Placebo Comparator Other
thiopental,0.9% normal saline

Sponsors

ramathibodi hospital
Lead Sponsor
ramathibodi hospital
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. upper-lower blephaloplasty and rhinoplasty with local anesthesia technic 2. age limit 18-65 year 3. body weight limit 40-100 kg

Exclusion criteria

Exclusion criteria: 1. cannot used thiopental 2. ASA class III-IV 3. underlying disease: obstructive sleep apnea, gastroesophageal reflux disease, obesity (body mass index ≥35) 4. coagulopathy 5. revision surgery 6. allergic to thiopental 7. chronic used opioid 8. deny to joint

Design outcomes

Primary

MeasureTime frame
pain immediate-post operation visaul analog score

Secondary

MeasureTime frame
complication immediate-post operation questionnaire interview and vital sign mornitering

Contacts

Public Contactsoisuda thanahirunrojh

Unaffiliated.

soisuda.tha@gmail.com0894680228

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026